Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a study of BG00012 plus methotrexate in active rheumatoid arthritis with inadequate response to conventional DMARDs
2008-004754-33Phase 2Completed
- Sponsor
- Biogen
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing BG00012 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: ACR20 response at week 12. Started Nov 2008; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-004754-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004754-33.